Development and Validation of Personalized Digital Healthcare Technology and Service Model for the Management and Recovery of Side Effects of Treatment in Breast Cancer Survivors

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The ultimate goal of this research and development is to develop personalized digital healthcare technologies and self-management strategies based on self-assessment results and evidence, for breast cancer survivors who require management and recovery from acute and chronic side effects related to various treatments (surgery, chemotherapy, radiation, hormone therapy, etc.). Additionally, the aim is to verify the clinical applicability and establish a service model to address the diverse unmet healthcare needs of breast cancer survivors.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Individuals who have undergone surgery for Stage 1-2 breast cancer

• Individuals who have had a unilateral mastectomy

• Aged 18 years or older and under 65 years

• Possessing a smartphone with either an Android or iOS operating system

• Individuals who voluntarily decide to participate after receiving detailed information about the study and provide written consent

Locations
Other Locations
Republic of Korea
Samsung Medical Center
RECRUITING
Seoul
Contact Information
Primary
Sun Woo Kim, MS
k.sunwoo0418@gmail.com
+82-2-2008-4192
Time Frame
Start Date: 2024-11-13
Estimated Completion Date: 2025-05-31
Participants
Target number of participants: 72
Treatments
No_intervention: control (Conventional Treatment)
* breast cancer surgery with CTx/RTx/HTx~* brochure training
Experimental: intervention (digital health)
* breast cancer surgery with CTx/RTx/HTx~* brochure training~* add digital health (application + smartwatch)
Related Therapeutic Areas
Sponsors
Collaborators: Pusan National University Yangsan Hospital
Leads: Samsung Medical Center

This content was sourced from clinicaltrials.gov